The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.
Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, Vanni I, Boccardo S, Rijavec E, Genova C, Biello F, Barletta G, Rossi G, Tagliamento M, Maggioni C, Grossi F.
Dal Bello MG, et al. Among authors: tagliamento m.
J Transl Med. 2019 Mar 8;17(1):74. doi: 10.1186/s12967-019-1828-0.
J Transl Med. 2019.
PMID: 30849967
Free PMC article.